AA
VIRX

AlphaMark Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

AlphaMark Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$1K – 748
2022
Q3 		$1K Hold
200
– – ﹤0.01% 673
2022
Q2 		$1K Buy
+200
New +$1K ﹤0.01% 616